Skip to main content
SpringerLink
Log in

Prevention of Coronary Heart Disease

  • Chapter
Book cover Integrating Cardiology for Nuclear Medicine Physicians

Abstract

Coronary heart disease (CHD) is a leading cause of death in the USA, and a burden that is estimated to overtake all other causes of mortality worldwide by the year 2020 [1]. Marked advances have been made in recent years to better understand the pathophysiology of CHD and to develop scoring systems that can integrate risk factors to estimate an individual’s risk of future cardiovascular (CV) events. Risk factors for CHD are divided into modifiable (smoking, hypertension, lipid abnormalities, diabetes, sedentary lifestyle) and nonmodifiable (age, male gender, genetic factors, ethnicity). Interventions aimed at prevention can be divided into primary (disease prevention in patients without overt cardiovascular disease) as opposed to secondary, when dealing with those with known cardiovascular disease (CVD). The following is an overview of interventions aimed at prevention of CHD.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Murray CJ, Lopez AD (1997) Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 349:1498–1504.

    Article  PubMed  CAS  Google Scholar 

  2. Howard G, Wagenknecht LE, Burke GL et al. (1998) Cigarette smoking and progression of atherosclerosis: The Atherosclerosis Risk in Communities (ARIC) Study. J Am Med Assoc 279(2):119–124.

    Article  CAS  Google Scholar 

  3. Mahonen MS, McElduff P, Dobson AJ et al. (2004) Current smoking and the risk of non-fatal myocardial infarction in the WHO MONICA Project populations. Tob Control 3(3):244–250.

    Article  Google Scholar 

  4. Prescott E, Scharling H, Osler M, Schnohr P (2002) Importance of light smoking and inhalation habits on risk of myocardial infarction and all cause mortality. A 22 year follow up of 12 149 men and women in The Copenhagen City Heart Study. J Epidemiol Community Health 56(9):702–706.

    Article  PubMed  CAS  Google Scholar 

  5. Law MR, Wald NJ (2003) Environmental tobacco smoke and ischemic heart disease. Prog Cardiovasc Dis 46(1):31–38.

    Article  PubMed  Google Scholar 

  6. Godtfredsen NS, Holst C, Prescott E et al. (2002) Smoking reduction, smoking cessation, and mortality: A 16-year follow-up of 19,732 men and women from The Copenhagen Centre for Prospective Population Studies. Am J Epidemiol 156:994.

    Article  PubMed  Google Scholar 

  7. Kawachi I, Colditz GA, Stampfer MJ et al. (1994) Smoking cessation and time course of decreased risks of coronary heart disease in middle-aged women. Arch Intern Med 154(2):169–175.

    Article  PubMed  CAS  Google Scholar 

  8. Critchley JA, Capewell S (2003) Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review. J Am Med Assoc 290(1):86–97.

    Article  Google Scholar 

  9. A clinical practice guideline for treating tobacco use and dependence: A US Public Health Service report (2000) The Tobacco Use and Dependence Clinical Practice Guideline Panel, Staff, and Consortium Representatives. J Am Med Assoc 283(24):3244–54.

    Google Scholar 

  10. Kuller LH (2006) Prevention of coronary heart disease and the National Cholesterol Education Program. Circulation 113(5):598–600.

    Article  PubMed  Google Scholar 

  11. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (2001) Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). J Am Med Assoc 285(19):2486–2497.

    Article  Google Scholar 

  12. American Heart Association (2005) Heart and Stroke Statistics – 2005 Update. Dallas, Texax, American Heart Association.

    Google Scholar 

  13. Chobanian AV, Bakris GL, Black HR et al. (2003) The seventh report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure: the JNC 7 report. J Am Med Assoc 289(19):2560–2572.

    Article  CAS  Google Scholar 

  14. Staessen JA, Wang JG, Thijs L (2001) Cardiovascular protection and blood pressure reduction: a meta-analysis. Lancet 358(9290):1305–1315.

    Article  PubMed  CAS  Google Scholar 

  15. Geiss LS, Herman WH, Smith PJ (1995) National Diabetes Data Group. Diabetes in America. Bethesda, Md: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, pp. 233–257.

    Google Scholar 

  16. Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA et al. (2000) Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. Br Med J 321:405–412.

    Article  CAS  Google Scholar 

  17. Arauz-Pacheco C, Parrott MA, Raskin P (2002) (American Diabetes Association). Hypertension management in adults with diabetes. Diabetes Care 25(1):134–147.

    Article  PubMed  Google Scholar 

  18. Colwell JA (2004) American Diabetes Association. Aspirin therapy in diabetes. Diabetes Care 27 Suppl 1:S72–S73.

    PubMed  Google Scholar 

  19. Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O (2003) Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 348(5):383–93.

    Article  PubMed  Google Scholar 

  20. Hedley AA, Ogden CL, Johnson CL, Carroll MD, Curtin LR, Flegal KM  (2004) Overweight and obesity among US children, adolescents, and adults, 1999-2002.  J Am Med Assoc 291:2847–2850.

    Article  CAS  Google Scholar 

  21. Poirier P, Giles TD, Bray GA et al. (2006) American Heart Association; Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 113(6):898–918.

    Article  PubMed  Google Scholar 

  22. Yancy WS Jr, Westman EC, French PA, Califf RM (2003) Diets and clinical coronary events: the truth is out there. Circulation 107(1):10–6.

    Article  PubMed  Google Scholar 

  23. Vivekananthan DP, Penn MS, Sapp SK, Hsu A, Topol EJ (2003) Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials. Lancet 361(9374):2017–23.

    Article  PubMed  CAS  Google Scholar 

  24. Mukamal KJ, Conigrave KM, Mittleman MA et al. (2003) Roles of drinking pattern and type of alcohol consumed in coronary heart disease in men. N Engl J Med 348:109–118.

    Article  PubMed  Google Scholar 

  25. Berlin JA, Colditz GA (1990) A meta-analysis of physical activity in the prevention of coronary heart disease. Am J Epidemiol 132:612–628.

    PubMed  CAS  Google Scholar 

  26. Blair SN, Kohl HW 3d, Barlow CE, Paffenberger RS Jr, Gibbons LW, Macera CA (1995) Changes in physical fitness and all-cause mortality. A prospective study of healthy and unhealthy men. J Am Med Assoc 273:1093–1098.

    Article  CAS  Google Scholar 

  27. Pate RR, Pratt M, Blair SN et al. (1995) Physical activity and public health: a recommendation from the Centers for Disease Control and Prevention and the American College of Sports Medicine. J Am Med Assoc 273:402–407.

    Article  CAS  Google Scholar 

  28. Thompson PD, Buchner D, Pina I et al. (2003) Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease: a statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity). Circulation 107:3109–3116.

    Article  PubMed  Google Scholar 

  29. Taylor RS, Brown A, Ebrahim S et al. (2004) Exercise-based rehabilitation for patients with coronary heart disease: systematic review and meta-analysis of randomized controlled trials. Am J Med 116:682–692.

    Article  PubMed  Google Scholar 

  30. Eidelman RS, Hebert PR, Weisman SM, Hennekens CH (2003) An update on aspirin in the primary prevention of cardiovascular disease. Arch Internal Med 163(17):2006–2010.

    Article  Google Scholar 

  31. Pearson TA, Blair SN, Daniels SR et al. (2002) AHA guidelines for primary prevention of cardiovascular disease and stroke: 2002 update: consensus panel guide to comprehensive risk reduction for adult patients without coronary or other atherosclerotic vascular diseases. American Heart Association Science Advisory and Coordinating Committee. Circulation 106:388–391.

    Article  PubMed  Google Scholar 

  32. Antiplatelet Trialists’ Collaboration (1994) Collaborative overview of randomised trials of anti platelet therapy – I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Br Med J 308:81–106.

    Google Scholar 

  33. Freemantle N, Cleland J, Young P, Mason J, Harrison J (1999) β Blockade after myocardial infarction: systematic review and meta regression analysis. Br Med J 318:1730–1737.

    CAS  Google Scholar 

  34. Teo KK, Yusuf S, Pfeffer M et al. (2002) Effects of long-term treatment with angiotensin-converting-enzyme inhibitors in the presence or absence of aspirin: a systematic review. Lancet 360:1037–1043.

    Article  PubMed  CAS  Google Scholar 

  35. Pfeffer MA, Swedberg K, Granger CB et al. (2003) Effects of candesartan on mortality and morbidity in patients with chronic heart failure: The CHARM-Overall programme. Lancet 362:759–766.

    Article  PubMed  CAS  Google Scholar 

  36. Pignone M, Earnshaw S, Tice JA, Pletcher MJ (2006) Aspirin, statins, or both drugs for the primary prevention of coronary heart disease events in men: a cost-utility analysis. Ann Internal Med 144(5):326–336.

    Google Scholar 

  37. Grundy SM, Cleeman JI, Bairey Merz CN et al. (2004) For the Coordinating Committee of the National Cholesterol Education Program. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 110:227–239.

    Article  PubMed  Google Scholar 

  38. Go AS, Iribarren C, Chandra M et al. (2006) Statin and beta-blocker therapy and the initial presentation of coronary heart disease. Ann Internal Med 144(4):229–238.

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The Brody School of Medicine, Department of Medicine, Section of Cardiology, East Carolina University, 28858-4354, Greenville, NC, USA

    Firas A. Ghanem & Assad Movahed

Authors
  1. Firas A. Ghanem
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Assad Movahed
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. The Brody School of Medicine, Department of Medicine, Section of Cardiology, East Carolina University, 600 Moye Blvd., 27858-4354, Greenville, NC, USA

    Assad Movahed

  2. Department of Nuclear Medicine, Guy’s & St Thomas’ Hospital NHS Foundation Trust, St. Thomas Street, SE1 9RT, London, UK

    Gopinath Gnanasegaran

  3. Department of Nuclear Medicine, Royal Free Hospital, Pond Street, NW3 2QG, London, UK

    John Buscombe  & Margaret Hall  & 

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Ghanem, F., Movahed, A. (2009). Prevention of Coronary Heart Disease. In: Movahed, A., Gnanasegaran, G., Buscombe, J., Hall, M. (eds) Integrating Cardiology for Nuclear Medicine Physicians. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-78674-0_36

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-78674-0_36

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-78673-3

  • Online ISBN: 978-3-540-78674-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation